CORMIO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 3.264
EU - Europa 702
AS - Asia 280
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 4.252
Nazione #
US - Stati Uniti d'America 3.264
CN - Cina 262
SE - Svezia 230
UA - Ucraina 122
IT - Italia 113
DE - Germania 90
FI - Finlandia 70
GB - Regno Unito 38
BE - Belgio 13
FR - Francia 10
IE - Irlanda 8
IN - India 5
VN - Vietnam 5
IR - Iran 4
AT - Austria 3
AU - Australia 3
KR - Corea 3
RU - Federazione Russa 3
A2 - ???statistics.table.value.countryCode.A2??? 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
Totale 4.252
Città #
Woodbridge 423
Fairfield 406
Chandler 349
Jacksonville 294
Houston 246
Ashburn 202
Nyköping 196
Cambridge 163
Seattle 146
Wilmington 144
Ann Arbor 135
Roxbury 79
Lawrence 76
Nanjing 75
Beijing 61
Bari 60
Des Moines 43
Inglewood 28
Princeton 28
Nanchang 25
New York 21
Jiaxing 19
San Diego 18
Boardman 17
Hebei 17
Shenyang 16
Dearborn 15
Arzano 13
Brussels 13
Brooklyn 11
Tianjin 11
Changsha 9
Dublin 7
Dong Ket 5
Helsinki 5
Kunming 5
London 5
Los Angeles 5
Paris 5
Pune 5
Washington 5
Auburn Hills 4
Hefei 4
Jinan 4
Guangzhou 3
Indiana 3
Redwood City 3
Vienna 3
Ardabil 2
Augusta 2
Buffalo 2
Hangzhou 2
Lecce 2
Mainz 2
Norwalk 2
Rome 2
Sannicandro di Bari 2
Sydney 2
Taizhou 2
Acton 1
Barletta 1
Bisceglie 1
Brindisi 1
Budapest 1
Cairo 1
Canberra 1
Castellammare Di Stabia 1
Cerignola 1
Como 1
Copenhagen 1
Cormeilles-en-Parisis 1
Dallas 1
Detroit 1
Edinburgh 1
Frankfurt am Main 1
Hounslow 1
Huzhou 1
Kansas City 1
Lanzhou 1
Manchester 1
Matera 1
Ningbo 1
Noicattaro 1
Nürnberg 1
Oldham 1
Perugia 1
Prescot 1
Redmond 1
Riva 1
Robertstown 1
Saint Petersburg 1
San Francisco 1
San Mateo 1
Stockholm 1
Tel Aviv 1
Torino 1
Triggiano 1
Viterbo 1
Wenzhou 1
Xian 1
Totale 3.493
Nome #
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 138
Increase in proteins involved in mitochondrial fission, mitophagy, proteolysis and antioxidant response in type I endometrial cancer as an adaptive response to respiratory complex I deficiency 106
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 99
Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling 99
MtDNA content in the progression of endometrial pathology from normal endometrium to hyperplasia to type I endometrial carcinoma 87
Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer’s disease patients 87
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 87
Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. 86
Variations at the H-strand replication origins of mitochondrial DNA and mitochondrial DNA content in the blood of type 2 diabetes patients 85
null 84
Mitochondrial changes in endometrial carcinoma: Possible role in tumor diagnosis and prognosis (Review) 83
Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression 83
Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells 82
Molecular markers in bladder cancer: Novel research frontiers 81
The PGC-1a-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. 79
Mitochondrial DNA mutations in RRF of healthy subjects of different age 77
MtDNA deletions in aging and in non mitochondrial pathologies 74
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 74
null 71
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 71
Mitochondrial DNA genotyping reveals synchronous nature of simultaneously detected endometrial and ovarian cancers 66
Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma 66
null 65
Mitochondrial DNA Backgrounds Might Modulate Diabetes Complications Rather than T2DM as a Whole 64
Analysis of Post-Translational Modified Forms of the Mitochondrial Antioxidant Protein Peroxiredoxin 3 in Lon Protease Knock-Down Cell Line 63
Mitochondrial dysfunctions in bladder cancer: exploring their role as disease markers and potential therapeutic targets 63
Age-related alterations of mitochondrial and of nuclear-mitochondrial cross-talk in the human skeletal muscle 61
Complex I deficiency associated to mitochondrial DNA mutations in type I endometrial carcinoma 61
A distruptive mitochondrial DNA mutation in respiratory complex I: Two-dimensional electrophoresis analysis of mitochondrial proteome of cybrid cell lines. 60
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 59
Mitochondrial DNA and aging 58
Depletion of mitochondrial DNA in the skeletal muscle of two cirrhotic patients with severe asthenia 58
null 57
Low levels of 4977 BP-deleted molecules of mitochondrial DNA in the presence of high OH(8)DG contents in healthy subjects and Alzheimer's disease patients 56
EFFECTS OF THE MITOCHONDRIAL LON PROTEASE INACTIVATION ON THE MITOCHONDRIAL ANTIOXIDANT PROTEIN PEROXIREDOXIN 3 56
Alterazioni fenotipiche e genotipiche mitocondriali legate all'età nel muscolo scheletrico umano 56
Age-related alterations of mitochondria and of the nuclear-mitochondria cross-talk in skeltal muscle 54
Mitochondrial DNA mutations in ragged red fibers of healthy individuals of different age 54
DNA mitocondriale ed invecchiamento 53
Mitochondrial genotypic and phenotypic alterations in human skeletal muscle 53
Regolazione età-dipendente dell'espressione di NRF-1 e mtTFA nel muscolo sceletrico umano 52
Mitochondria in Aging Human Skeletal Muscle 51
Caratterizzazione istochimica e ricerca di delezioni mitocondriali in muscoli scheletrici di individui di diversa età 50
Aging and mitochondria biogenesis 50
Analysis of mitochondrial proteome of cybrid cell harbouring a disruptive mitochondrial DNA mutation in respiratory complex I. 50
Analysis of mitochondrial DNA sequence variations in type 2 Diabetes patients charactherized for haplogroup affiliation 50
Analysis of Mitochondrial Proteome of Cybrid Cells Harbouring a Truncative Mitochondrial DNA Mutation in Respiratory Complex I. Molecular BioSystems. 50
Pathogenic Mitochondrial DNA Mutations Correlate with Oncocytic Change and Mitochondrial Biogenesis Increase in Type I Endometrial Carcinoma. 49
Mitochondrial histochemical characterization and DNA deletions research in skeletal muscles of different ages individuals 48
Aging and mitochondria 48
Cybrid Cell Lines As a Model to Study the Effects of Mitochondrial DNA Mutations on the Mitochondrial Proteome. 46
Indagine su larga scala di danni mitocondriali legati all'età nel muscolo scheletrico umano 46
Rat hindlimb unloading: Soleus and Extensor Digitorum Longus histochemistry, mitochondrial DNA content and mitochondrial DNA deletions 46
Aging and mitochondria 46
Age-related alterations of mitochondria and NRF-1 and mtTFA expression in the human skeletal muscle 44
Age-related regulation of the expression of the NRF-1 and TFAM genes in human skeletal muscle 44
Mitochondrial DNA deletions in oculopharyngeal muscolar dystrophy 43
Mitochondrial proteome of cybrids cells harbouring a truncative mitochondrial DNA mutation in respiratory complex I 43
Mitochondrial biogenesis increases in hyperplasia and type I endometrial carcinoma. 39
Delezioni del DNA mitocondriale e attività citocromo ossidasica nei muscoli scheletrici di individui di varie età 35
Age, mitochondria and bladder cancer 33
PGC-1alpha-dependent pathway for mitochondrial biogenesis activation is upregulated in type I endometrial cancer 32
Mitochondrial proliferation and regulation of NRF-1 and mtTFA expression in aging human skeletal muscle 32
Aumento dell'espressione di NRF-1 e mtTFA nel muscolo scheletrico umano durante l'invecchiamento 32
Trascrizione età-dipendente di NRF-1 e mtTFA nel muscolo scheletrico umano 31
Area-specific differences in OH8dG and mtDNA4977 levels in Alzheimer’s disease patients and aged controls 30
Large scale analysis of age-related mitochondrial damages in human skeletal muscle 28
Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle 25
I mitocondri nell'invecchiamento di uomo e di ratto: un confronto tra due specie evolutivamente distanti 24
null 24
Age-related changes of mitochondrial DNA content and mitochondrial genotypic and phenotypic alterations in rat hind-limb skeletal muscles 24
Proliferazione mitocondriale e regolazione dell'espressione di NRF-1 e mttFA nel muscolo scheletrico umano durante l'invecchiamento 22
Trascrizione età-dipendente di NRF-1 e mtTFA nel muscolo scheletrico umano 22
Mitochondrial DNA Mutations Correlate with Mitochondrial Biogenesis Increase and Oncocytic Change in Type I Endometrial Carcinoma. 21
Mitochondrial DNA and aging 21
NRF-1 and mtTFA expression in the mitochondrial proliferation of aging human skeletal muscle 21
Mitochondrial DNA mutations within the progression model of type I endometrial carcinoma 19
Mitochondrial caseinolytic protease p: A possible novel prognostic marker and therapeutic target in cancer 18
The PGC-1alpha-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer 18
Mitochondria in aging human skeletal muscle 17
Increased expression of mitochondrial transcription factor A and nuclear respiratory factor 1 in skeletal muscle from aged human subjects 16
null 15
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 11
null 9
Molecular markers predicting disease outcome in bladder cancer. Should we shift from the classical cell-cycle regulators to her2 oncogene? 8
Modulation of the activity of human mitochondrial protease complex ClpXP as potential therapeutic strategy for cancer 6
Micropapillary bladder cancer, a variant histology of the elderly 4
Ovarian Cancer: A Landscape of Mitochondria with Emphasis on Mitochondrial Dynamics 3
Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions 2
Totale 4.414
Categoria #
all - tutte 16.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019299 0 0 0 0 0 0 0 0 0 62 119 118
2019/20201.057 209 59 23 87 113 68 117 78 135 58 94 16
2020/2021692 85 27 56 21 142 22 67 34 64 96 49 29
2021/2022539 21 107 12 20 11 14 26 28 43 35 88 134
2022/2023878 126 84 70 81 93 120 7 98 145 2 22 30
2023/2024274 18 60 13 85 33 53 1 1 4 6 0 0
Totale 4.414